Policy & Regulation
US CDC, FDA Recommend Halt on Use of Johnson and Johnson COVID-19 Vaccine
14 April 2021 - - On April 13 the The United States Centers for Disease Control (CDC) and the US Food and Drug Administration (FDA) issued joint statements regarding the safety of US-based healthcare ...
Infinity BiologiX Awarded CDC Contract to Sequence Variants of COVID-19 Virus and Assist in Global Public Health Response
14 April 2021 - - US-based central laboratory Infinity BiologiX has been awarded a contract from the Centers for Disease Control and Prevention "Genomic Surveillance for SARS-CoV-2 Variants,"...
Endourage Begins Human Clinical Trial to Test If Proprietary Hemp-Flower Formulation Eases Symptoms of Post-Acute COVID-19 Syndrome
14 April 2021 - - Denver, US-based CBD company Endourage has received authorization from an Institutional Review Board for its Phase IV clinical trial to evaluate the efficacy of its proprietary hemp ...
Mexican government announces development of Patria COVID-19 vaccine
14 April 2021 - Mexico's Director of the National Council of Science and Technology (Conacyt) has announced the development of a Mexican-made COVID-19 vaccine, 'Patria', CNN news websit...
Akers' proposed merger partner MyMD Pharmaceuticals to begin COVID-19 inflammatory depression trial
14 April 2021 - Akers Biosciences Inc (NASDAQ:AKER) said on Tuesday that its pharmaceutical partner MyMD Pharmaceuticals Inc has signed an agreement with a medical school to conduct a Phase 2 clinical...
Bausch + Lomb announces top line results from first phase 3 NOV03 (perfluorohexyloctane) trial in dry eye disease associated with meibomian gland dysfunction
14 April 2021 - Canada-based Bausch + Lomb, a global eye health business of Bausch Health Companies Inc (NYSE/TSX: BHC), and Novaliq GmbH, a biopharmaceutical company focusing on ocular therapeutics, ...